Investing for Impact against Tuberculosis and HIV
- Sub-Saharan Africa
Nigeria has the second highest burden of HIV in Africa, which presents a formidable challenge to a nation that struggles to provide the full range of needed HIV services. The Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund) awarded a grant to FHI 360 to serve as an HIV principal recipient to combat HIV and AIDS in Nigeria. The Investing for Impact against Tuberculosis and HIV project will move the country closer to its goal of expanding prevention, treatment, care and support to reduce the incidence of HIV and its associated deaths and illness. The project will also provide tuberculosis (TB) screening for people with HIV, referrals for treatment for those found to have TB and isoniazid prophylactic therapy for those who do not. HIV testing will be integrated in TB clinics for more effective delivery of services.
Groups that the project will focus on include adults — particularly women — and children living with HIV, pregnant women, young women and girls, and key populations (sex workers, men who have sex with men, transgender persons and people who inject drugs).
This project will build on the results achieved under previous and current Global Fund grants. Our work to scale up HIV treatment efforts will focus on five of the six high-burden states (Akwa Ibom, Imo, Kaduna, Oyo and Rivers). Scaling up prevention of mother-to-child-transmission services will focus on 12 high-burden states (Akwa Ibom, Benue, Cross River, Imo, Kaduna, Kano, Lagos, Nasarawa, Oyo, Rivers, Sokoto and Taraba) plus the Federal Capital Territory.